ArticleUpdates in surgery2026
Efficacy and safety of adjuvant targeted therapy plus immunotherapy in hepatocellular carcinoma patients with high-risk recurrence factors after hepatectomy.
Mengmeng Zhang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.